29 January 2021 in The Journal of Sexual Medicine
Background: Vaginal stenosis (VS) is a common side effect of pelvic radiotherapy for gynecological cancer in women. It has a high incidence variability, likely due to unstandardized and subjective assessment methods. Furthermore, even though the worldwide standard treatment for VS is vaginal dilation, low compliance rates have been noted.Aim: To evaluate the parameters used to diagnose VS and to assess whether the lack of an objective measure of VS hampers vaginal dilator use.Methods: A systematic review in accordance with the PRISMA reporting guidelines was conducted. PubMed, EMBASE, and Web of Science databases were searched. Randomized trials and prospective, retrospective, and cross-sectional studies published from January 2011 to February 2020 were included.Outcomes: The main outcome of this study was a review of the published literature on assessment methods for VS and compliance to vaginal dilator use.RESULTS: Of the 28 articles obtained, only 7 used objective methods to measure the vaginal volume. 3 studies have demonstrated patient’s concern with VS development and showed a high compliance to dilator use, whereas others reported several barriers to dilator use.Clinical Implications: Lack of an objective assessment method can be a predisposing factor for uncertain VS incidence rates and impair compliance to vaginal dilator therapy, leading to long-term VS and sexual dysfunction.Strengths & Limitations: This is the first systematic review on the heterogeneity of VS evaluation methods and compliance to vaginal dilator use. All studies were comprehensively evaluated by 2 reviewers. The limitations included the heterogeneity of the study designs and the unstandardized criteria used to classify stenosis or to evaluate compliance to dilator use. Although 3 well-known databases were used, the inclusion of more data sources could have increased the number of publications included in this review.CONCLUSION: VS is frequently diagnosed using subjective parameters. Few unstandardized objective methods are used to evaluate this condition. Regarding compliance to vaginal dilator use, there was a high dropout rate during follow-up and no consensus on starting time or ideal usage.
1 January 2025 in Fisioterapia e Pesquisa
Although it is advised to use vaginal dilators following radiotherapy to prevent vaginal stenosis, compliance is frequently low. This study aimed to assess adherence to the use of vaginal dilators after brachytherapy and its effects in women who received phone call or texting apps guidance. A total of 30 women who previously underwent brachytherapy for cervical cancer were randomized into two groups using the R program: monitoring via phone calls and monitoring via text messages. They underwent gynecological examination with measurement of vaginal volume and answered the Functional Assessment of Cancer Therapy-Cervix Cancer (FACT-CX) questionnaire at the initial consultation and at the sixth month. No association was found between adherence and the types of follow-up (p=0.79). In the first month, 43.3% adhered to dilators, 36.6% did so in the third month, and 23% in the sixth month. The highest adherence group had higher difference in vaginal volume scores (16.81±10.45 cm3) compared to the nonadherence group (10.45±9.55 cm3) with a strong effect size (d=1.68). The difference between the initial and final vaginal volume was not associated with the FACT-CX scores (rho=−0.369; p=0.08. Although no differences were observed in adherence to dilators and type of follow-up, high adherence demonstrated a direct effect on increasing vaginal volume, showing the need to promote educational forms that encourage adherence.
1 January 2025 in Fisioterapia e Pesquisa
RESUMO Embora seja aconselhado o uso de dilatadores vaginais após a radioterapia para prevenir a estenose vaginal, a adesão frequentemente é baixa. O objetivo deste estudo foi avaliar a adesão ao uso de dilatadores vaginais após a braquiterapia e seus efeitos em mulheres que receberam orientações por telefone ou aplicativos de mensagens de texto. Trinta mulheres previamente submetidas à braquiterapia para câncer cervical foram randomizadas por meio do programa R, em dois grupos: acompanhamento por telefone; e monitoramento via mensagens de texto. Todas realizaram exame ginecológico com aferição do volume vaginal e responderam ao questionário Functional Assessment of Cancer Therapy-Cervix Cancer (FACT-CX) na consulta inicial e no sexto mês. Não foi encontrada associação entre adesão e tipos de acompanhamento (p=0,79). No primeiro mês, 43,3% aderiram aos dilatadores, 36,6% no terceiro mês e 23% no sexto mês. O grupo de maior adesão teve maior diferença nos escores de volume vaginal (16,81±10,45 cm3) em comparação com o grupo de não adesão (10,45±9,55 cm3) com um tamanho de efeito forte (d=1,68). A diferença entre o volume vaginal inicial e final não apresentou relação com os escores do FACT-CX (rho=−0,369; p=0,08). Embora não tenham sido observadas diferenças na adesão aos dilatadores e no tipo de acompanhamento, a alta adesão demonstrou efeito direto no aumento do volume vaginal, mostrando a necessidade de promover formas educativas que estimulem a adesão.